This Article Full Text Full Text (PDF) All Versions of this Article: 0008-5472.CAN-09-0529v1 69/19/7569    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Li, Y. Articles by Abounader, R. PubMed PubMed Citation Articles by Li, Y. Articles by Abounader, R.

MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes

Departments of ¹ Microbiology, ² Neurology and ³ Pathology, University of Virginia, Charlottesville, Virginia; and ⁴ College of Pharmacy, Ohio State University, Columbus, Ohio

Requests for reprints: Roger Abounader, Department of Microbiology, University of Virginia, P.O. Box 800168, Charlottesville, VA 22908. Phone: 434-982-6634; Fax: 434-982-4467; E-mail: ra6u{at}virginia.edu.

Key Words: glioma • medulloblastoma • miR-34a

MicroRNA-34a (miR-34a) is a transcriptional target of p53 that is down-regulated in some cancer cell lines. We studied the expression, targets, and functional effects of miR-34a in brain tumor cells and human gliomas. Transfection of miR-34a down-regulated c-Met in human glioma and medulloblastoma cells and Notch-1, Notch-2, and CDK6 protein expressions in glioma cells. miR-34a expression inhibited c-Met reporter activities in glioma and medulloblastoma cells and Notch-1 and Notch-2 3'-untranslated region reporter activities in glioma cells and stem cells. Analysis of human specimens showed that miR-34a expression is down-regulated in glioblastoma tissues as compared with normal brain and in mutant p53 gliomas as compared with wild-type p53 gliomas. miR-34a levels in human gliomas inversely correlated to c-Met levels measured in the same tumors. Transient transfection of miR-34a into glioma and medulloblastoma cell lines strongly inhibited cell proliferation, cell cycle progression, cell survival, and cell invasion, but transfection of miR-34a into human astrocytes did not affect cell survival and cell cycle status. Forced expression of c-Met or Notch-1/Notch-2 transcripts lacking the 3'-untranslated region sequences partially reversed the effects of miR-34a on cell cycle arrest and cell death in glioma cells and stem cells, respectively. Also, transient expression of miR-34a in glioblastoma cells strongly inhibited in vivo glioma xenograft growth. Together, these findings represent the first comprehensive analysis of the role of miR-34a in gliomas. They show that miR-34a suppresses brain tumor growth by targeting c-Met and Notch. The results also suggest that miR-34a could serve as a potential therapeutic agent for brain tumors. [Cancer Res 2009;69(19):7569–76]